|
|
Volumn 65, Issue 7, 2005, Pages 1144-1145
|
|
The role of radiotracer imaging in Parkinson disease [1] (multiple letters)
a a a a a a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBIDOPA;
DOPA;
ENTACAPONE;
FLUORINE DERIVATIVE;
FLUORODOPA F 18;
IOFLUPANE I 123;
TRACER;
UNCLASSIFIED DRUG;
2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE;
2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE;
DIAGNOSTIC AGENT;
TROPANE DERIVATIVE;
DOPAMINE;
DRUG DERIVATIVE;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC IMAGING;
DIAGNOSTIC VALUE;
DISEASE COURSE;
DISEASE MARKER;
DOPAMINERGIC SYSTEM;
HUMAN;
IMAGE RECONSTRUCTION;
LETTER;
NEUROIMAGING;
NIGRONEOSTRIATAL SYSTEM;
PARKINSON DISEASE;
PARKINSONISM;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SCREENING TEST;
SENSITIVITY AND SPECIFICITY;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
CLINICAL TRIAL;
DIFFERENTIAL DIAGNOSIS;
METHODOLOGY;
NOTE;
PATHOPHYSIOLOGY;
PREDICTION AND FORECASTING;
REPRODUCIBILITY;
SCINTISCANNING;
STANDARD;
BRAIN;
ECONOMICS;
METABOLISM;
PATIENT SELECTION;
CLINICAL TRIALS;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
PARKINSON DISEASE;
PREDICTIVE VALUE OF TESTS;
REPRODUCIBILITY OF RESULTS;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
TROPANES;
BRAIN;
DIHYDROXYPHENYLALANINE;
DISEASE PROGRESSION;
DOPAMINE;
PATIENT SELECTION;
POSITRON-EMISSION TOMOGRAPHY;
|
|
EID: 26444469515
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/WNL.65.7.1144 Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|